Trilogy Capital’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
DSA
BHG
LAM
LCM
LBA
Trilogy Capital's ADNT Position: Q4 2018 in Review
Trilogy Capital sold out of Adient (ADNT) in Q4 2018, closing a stake of 1 share.
Trilogy Capital first reported a position in ADNT in Q4 2017 and held it in 4 quarters. The position peaked at $228K in Q4 2017. 347 funds tracked by Wall St. Rank hold ADNT as of Q4 2018.
- Trilogy Capital reported no remaining Adient position as of Q4 2018 after selling out during the quarter.
- Trilogy Capital sold 1 Adient share in Q4 2018.
- Trilogy Capital first reported a position in Adient in Q4 2017 and held it in 4 quarters.
- Trilogy Capital's Adient position peaked at $228K in Q4 2017.
- 347 funds tracked by Wall St. Rank held Adient as of Q4 2018.
Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.